ABSTRACT

Background: Cervical cancer remains a major public health concern, especially in low- and middle-income countries like Nigeria, where it is the second leading cause of cancer-related deaths among women. The disease is mainly caused by the Human Papillomavirus (HPV), and vaccination of girls aged 9–14 years is strongly recommended by the World Health Organization as an effective preventive measure. However, despite the vaccine’s proven safety and effectiveness, uptake in Nigeria is still low. This study assessed HPV vaccine uptake, willingness, and predictors among female secondary school students in Ekiti and Gombe States.
Material and methods: A comparative cross-sectional study was conducted among 576 female secondary school students selected through multistage sampling. Data was collected using semi-structured, interviewer-administered electronic questionnaires and analysed using SPSS version 26. Chi-square tests was used to test for associations, while binary logistic regression identified predictors of uptake. Statistical significance was set at p < 0.05.
Results: Overall HPV vaccine uptake was low at 83 (14.4%), with slightly higher uptake in Ekiti at 45 (15.6%) compared to Gombe at 38 (13.2%), but this was not statistically significant (p= 0.406). Willingness to receive the vaccine was relatively high, with 219 (76%) in Ekiti and 197 (68.4%) in Gombe, with a significant difference between the states (p < 0.001). In multivariate analysis, only knowledge (AOR = 9.027), age of respondents (AOR = 6.782), and perception (AOR = 2.036) emerged as predictors of uptake.
Conclusion: Despite high willingness, HPV vaccine uptake among respondents was low. Knowledge, perception, and age were key determinants. Strengthening school-based health education and expanding access through school vaccination programs are essential in improving uptake and reducing cervical cancer burden in Nigeria.

KEYWORDS 

Human Papillomavirus (HPV), HPV Vaccine, Cervical Cancer, Uptake, Ekiti State, Gombe State, Secondary school, Nigeria.

REFERENCES

1) World Health Organisation: Cervical cancer. (2019). Accessed: February 21, 2026: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
2) Mafiana JJ, Dhital S, Halabia M, Wang X: Barriers to uptake of cervical cancer screening among women in Nigeria: a systematic review. Afr Health Sci. 2022, 22:295–309. 10.4314/ahs.v22i2.33
3) Pathak P, Pajai S, Kesharwani H: A review on the use of the HPV vaccine in the prevention of cervical cancer. Cureus. 2022, 14:87-92. 10.7759/cureus.28710
4) World Health Organisation: WHO updates recommendations on HPV vaccination schedule. (2022). Accessed: February 21, 2026: https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule
5) Ogolla JO, Masinde DR, Mbeke AM: Factors associated with human papillomavirus vaccine uptake before the health awareness, learning and education intervention in Korogocho Informal Settlements in Nairobi County, Kenya. ecancermedicalscience. 2025, 19:1892. 10.3332/ecancer.2025.1892
6) Mengistie BA, Yirsaw AN, Lakew G, et al.: Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review. Front. Public Health. 2025, 13:1537250. 10.3389/fpubh.2025.1537250
7) Mwaba D, Khondowe S, Daka V, Mwanza P, Chisanga C, Kalasa H, Nambozi M: Human papillomavirus vaccine acceptability and its associated factors among mothers of female children 9 – 14 years in Ndola District of Zambia. Open J Obstet Gynecol. 2024, 14:1757-1774. 10.4236/ojog.2024.1411145
8) Akpor OA, Adeyiolu AT, Alade MI, Adebiyi S, Adeola RS, Adeyanju BT: Knowledge, attitude, and utilization of human papillomavirus vaccination among female undergraduates in Ekiti State, Nigeria. Afr J Reprod Health. 2023, 27:79-89. 10.29063/ajrh2023/v27i6s.10
9) Mohammed AZ, Tukur A, Osagie AI, Okoh EO. Uptake of human papilloma virus vaccine among students of tertiary institutions in Gombe State, Nigeria. Eur J Pharm Med. 2019, 6:163-68. Available from: https://www.researchgate.net/publication/341679632_UPTAKE_OF_HUMAN_PAPILOMA_VIRUS_VACCINE_AMONG_STUDENTS_OF_TERTIARY_INSTITUTIONS_IN_GOMBE_STATE_NIGERIA
10) Jacob SM, Diehl JC, Vdovine G, et al.: Schistosomiasis and Soil Transmitted Helminthiasis Among School Age Children: Impact of 3–5 Annual Rounds of Mass Drug Administration in Ekiti State, Southwest Nigeria. Trop Med Infect Dis. 2025,10:85-89. 10.3390/tropicalmed10040085
11) Government of Ekiti State, Nigeria: About Ekiti State. (2025). Accessed: February 21, 2026: https://www.ekitistate.gov.ng/about-ekiti
12) Gombe State Government: History of Gombe State. (2022). Accessed: March 28, 2026: http://gombestate.gov.ng/history-2/
13) Oxford Business Group. Gombe state’s young, growing population to play key role in development. (2024). Accessed: February 21, 2026: https://oxfordbusinessgroup.com/reports/nigeria/2024-report/gombe-state/upward-growth-a-young-expanding-population-is-expected-to-play-a-pivotal-role-in-the-states-continued-development-overview/
14) Musa A, Abba U, Isa YI, Jibril MB, Abdullahi MK: Knowledge, attitude and uptake of human papilloma virus vaccine among adolescents in Bauchi local government area of Bauchi State, Nigeria. IOSR J Dent Med Sci. 2024, 23:49–60. 10.9790/0853-2310074960
15) Ogbolu MO, Kozlovszky M: Assessment of HPV knowledge and awareness among students and staff at IBB university, Niger State, Nigeria: implications for health education and prevention. Healthcare. 2024, 12:665-68. 10.3390/healthcare12060665
16) Onasoga OA, Dosumu TO, Folarin AO, Shittu BM: Knowledge and uptake of human papillomavirus vaccine among female undergraduate students in north-central, Nigeria: a cross-sectional study. Int J Community Based Nurs Midwifery. 2025, 13:126-137. 10.30476/ijcbnm.2025.102762.2509
17) Agha S, Nsofor I: HPV vaccine uptake among adolescent girls in Nigeria: the complex role of caregivers’ education. PLOS ONE. 2025, 20:e0325684. 10.1371/journal.pone.0325684
18) Oluwole EO, Idowu OM, Adejimi AA, Balogun MR, Osanyin GE: Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria. J Fam Med Prim Care. 2019, 8:3627–33. 10.4103/jfmpc.jfmpc_520_19
19) Lawal AF, Issa A, Ibrahim OR, Adesokan AM, Saka MJ, Osagbemi KG: Factors associated with human papillomavirus vaccine Uptake among undergraduate students in a Nigerian University: a cross-sectional study. MedRxiv. 2025, 23:1-14. https://doi.org/10.1101/2025.10.15.25338122
20) Bruni L, Saura-Lázaro A, Montoliu A, et al.: HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med. 2021, 144:10-24. 10.1016/j.ypmed.2020.106399
21) Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW: Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med. 2013, 57:414–8. 10.1016/j.ypmed.2013.05.013
22) Ezenwa BN, Balogun MR, Okafor IP: Mothers’ human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, Nigeria. Int J Women’s Health. 2013, 5:371-7. 10.2147/IJWH.S44483
23) Morhason-Bello IO, Wallis S, Adedokun BO, Adewole IF: Willingness of reproductive-aged women in a Nigerian community to accept human papillomavirus vaccination for their children. J Obstet Gynaecol Res. 2015, 1:1621–9. 10.1111/jog.12775

Cite this article

Egwakhide, A., Adeniji, T., Adewemimo, T., Adamu, U. Y., Adam, F. B., Abubakar, S. S., & Joshua, I. A. (2026). North-South Disparities in Human Papillomavirus Vaccine Uptake and Willingness among Female Secondary School Students in Nigeria: Evidence from Ekiti and Gombe States. INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH, 5(8), 795-803. https://doi.org/10.58806/ijhmr.2026.v5i8n10